Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms MPD10 |
Target |
Mechanism SARS-CoV-2 Mpro inhibitors(SARS-CoV-2 main protease inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC45H61N9O11 |
InChIKeyFAJZFSMHQFCKIQ-FCKYKTSTSA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Coronavirus Infections | Preclinical | US | 29 Sep 2023 |